How can 340B covered entities comply with manufacturer ESP data requirements in 2026?

By 2026, manufacturers often require covered entities to share de‑identified claims data through portals like 340B ESP to maintain contract pharmacy access. Entities must ensure data accuracy, coordinate with TPAs, and align internal reviews with manufacturer systems to avoid suspensions and restricted 340B pricing.